Cross ntry Healthcare(US:CCRN) ZACKS·2024-11-07 02:00Core Insights - Cross Country Healthcare (CCRN) reported a revenue of $315.12 million for the quarter ended September 2024, reflecting a decline of 28.8% year-over-year, while EPS was $0.12 compared to $0.39 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $310.05 million by 1.63%, and the EPS surpassed the consensus estimate of $0.10 by 20% [1] Financial Performance Metrics - Nurse and allied staffing FTEs were reported at 7,660, slightly below the estimated 7,692 [3] - Physician staffing metrics showed days filled in HRS at 24,424, exceeding the average estimate of 18,841 [3] - Revenue per day filled for physician staffing was $2,058, higher than the estimated $1,889 [3] - Average revenue per FTE per day for nurse and allied staffing was $373, slightly above the estimated $370.50 [3] - Revenue from physician staffing was $50.27 million, surpassing the estimated $48.26 million, marking a 10% increase year-over-year [3] - Revenue from nurse and allied staffing was $264.85 million, compared to the estimated $261.73 million, but represented a significant decline of 33.2% year-over-year [3] Stock Performance - Cross Country's shares have decreased by 7.6% over the past month, contrasting with a 0.7% increase in the Zacks S&P 500 composite [4] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [4]